Sector: University & Research Institutions

Latest content

How platform technologies are reshaping life sciences IP value creation

Versatile biotechnologies are changing patterns of collaboration among healthcare innovators

10 February 2022

Latest Enlarged Board of Appeal referral is a must-watch for US applicants

EPO Board of Appeal seeks clarification on joint applicants approach to priority rights

04 February 2022

IPCom forms alliance with Chinese 5G lab Langbo

The pair say their strategic cooperation will start with in-house patent prosecution services with the potential to grow from there

02 February 2022

CRISPR IP deals continue apace despite legal battles

Spate of recent transactions show the value of gene-editing patents beyond Cas9

28 January 2022

Biden administration is right to pursue a ‘China Initiative’ reset

Even some of the programme’s architects seem to agree that it has strayed from initial focus on trade secrets and intellectual property

22 January 2022

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Australia under-invests in IP, and recent government proposals will not fix that

Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries

04 December 2021

Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin

The deal shows how privacy and silo barriers to the commercialisation of information are being overcome

29 November 2021

Nobel laureate’s troubles are a cautionary tale about the importance of university tech-transfer support

Tasuku Honjo’s recent patent battles highlight the potential IP dangers of academic collaborations

18 November 2021

Patent suits decline in Dusseldorf and Mannheim, but Munich’s docket is on the rise

Germany is Europe’s biggest and most active litigation forum, but subtle differences in case law and proceedings mean that plaintiffs have important choices to make about where to file their suits

16 November 2021

Unlock unlimited access to all IAM content